(adapted in part from applicant's description): This project examines the mechanism of action of the TFIIS (SII) transcript cleavage factor and its role in transcriptional regulation. SII stimulates transcription by binding to paused or arrested RNA polymerase II and activating a latent nuclease in the enzyme that cleaves the nascent transcript near its 3' end to enable readthrough of various blocks to chain elongation. This project will continue to explore SII's mechanism with a focus on its interaction with nascent RNA. The contact site of RNA on SII will be precisely mapped. Mutant SII proteins eliminating RNA contact will be generated and tested for in vitro activity and an ability to complement the phenotypes of an SII gene deletion in yeast. SII contact sites on the polymerase will be mapped by protease footprinting. Direct evidence for arrested RNA polymerase II on chromatin in vivo will be sought using nuclear run-on and chromatin immunoprecipitation assays with anti-polymerase antibodies. Genes with biased base content will be surveyed to see if NTP pools regulate elongation efficiency in a gene-specific manner in vivo. Another aim is to determine the mechanism used to regulate PUR5 expression in response to NTP pool reduction in yeast. This will include measurement of NTP pools under various growth conditions and in response to 6-azauracil, an inhibitor of UTP and GTP synthesis. Finally, mice disrupted for two SII family genes (TceaI and Tcea3) will be generated and analyzed for developmental phenotypes.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM046331-12
Application #
6519456
Study Section
Cell Development and Function Integrated Review Group (CDF)
Program Officer
Tompkins, Laurie
Project Start
1991-07-01
Project End
2004-06-30
Budget Start
2002-07-01
Budget End
2003-06-30
Support Year
12
Fiscal Year
2002
Total Cost
$266,000
Indirect Cost
Name
Emory University
Department
Biochemistry
Type
Schools of Medicine
DUNS #
042250712
City
Atlanta
State
GA
Country
United States
Zip Code
30322
O'Rourke, Thomas W; Reines, Daniel (2016) Determinants of Amyloid Formation for the Yeast Termination Factor Nab3. PLoS One 11:e0150865
Loya, Travis J; Reines, Daniel (2016) Recent advances in understanding transcription termination by RNA polymerase II. F1000Res 5:
O'Rourke, Thomas W; Loya, Travis J; Head, PamelaSara E et al. (2015) Amyloid-like assembly of the low complexity domain of yeast Nab3. Prion 9:34-47
Arndt, Karen M; Reines, Daniel (2015) Termination of Transcription of Short Noncoding RNAs by RNA Polymerase II. Annu Rev Biochem 84:381-404
Loya, Travis J; O'Rourke, Thomas W; Reines, Daniel (2013) Yeast Nab3 protein contains a self-assembly domain found in human heterogeneous nuclear ribonucleoprotein-C (hnRNP-C) that is necessary for transcription termination. J Biol Chem 288:2111-7
Loya, Travis J; O'Rourke, Thomas W; Degtyareva, Natalya et al. (2013) A network of interdependent molecular interactions describes a higher order Nrd1-Nab3 complex involved in yeast transcription termination. J Biol Chem 288:34158-67
Loya, Travis J; O'Rourke, Thomas W; Reines, Daniel (2012) A genetic screen for terminator function in yeast identifies a role for a new functional domain in termination factor Nab3. Nucleic Acids Res 40:7476-91
Reines, Daniel (2012) Decapping goes nuclear. Mol Cell 46:241-2
Jenks, M Harley; O'Rourke, Thomas W; Reines, Daniel (2008) Properties of an intergenic terminator and start site switch that regulate IMD2 transcription in yeast. Mol Cell Biol 28:3883-93
Kopcewicz, Katarzyna A; O'Rourke, Thomas W; Reines, Daniel (2007) Metabolic regulation of IMD2 transcription and an unusual DNA element that generates short transcripts. Mol Cell Biol 27:2821-9

Showing the most recent 10 out of 37 publications